-
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma
- Description
Summary from BioProject: "Renal medullary carcinoma (RMC) is a highly lethal malignancy that mainly afflicts young individuals of African descent and is resistant to all targeted agents used to treat other renal cell carcinomas. Comprehensive genomic and transcriptomic profiling of untreated primary RMC tissues was performed to elucidate the molecular landscape of these tumors. We found that RMC was...
- Subject
-
Carcinoma, MedullaryCarcinoma, Renal CellKidney Neoplasms
- Access Rights
- Free to All
-
AICDA-induced epigenetic plasticity accelerates germinal center-derived lymphomagenesis
- Authors
- Teater, MattElemento, OlivierMelnick, Ari M.
- Description
Summary from the GEO: "Epigenetic heterogeneity is emerging as a significant phenotypic feature of tumors. In diffuse large B-cell lymphomas (DLBCLs), increased cytosine methylation heterogeneity is associated with poor clinical outcome, yet the biological mechanisms driving epigenetic heterogeneity remain unclear. Activation-induced cytidine deaminase (AICDA), an enzyme that deaminates and facilitates...
- Subject
-
Cytidine DeaminaseGerminal CenterLymphoma, Large B-Cell, Diffuse
- Access Rights
- Free to All
-
Small RNAs from 11 Drosophila species
- Authors
- Mohammed, JaavedFlynt, Alex SLai, Eric C
- Description
Summary from the GEO: "Annotation of small RNAs from 11 Drosophila species for the purpose of non-coding RNA annotation and comparative genomics assessment." Overall design from the GEO: "Small RNA samples from 11 Drosophila species." Abstract Summary: "To assess miRNA evolution across the Drosophila genus, we analyzed several billion small RNA reads across 12 fruit fly species. These data permit...
- Subject
-
DrosophilaGenomicsRNA, Small UntranslatedRNA, Untranslated
- Access Rights
- Free to All
-
DNA Methylation Dynamics of Germinal Center B Cells Are Mediated by AID
- Authors
- Teater, MattElemento, Olivier
- Description
Summary from the GEO: "Changes in DNA methylation are required for the formation of germinal centers (GC), but the mechanisms of such changes are poorly understood. Activation-induced cytidine deaminase (AID) has been recently implicated recently in DNA demethylation through its deaminase activity coupled with DNA repair. We investigated the epigenetic function of AID in vivo in germinal center B...
- Subject
-
B-LymphocytesCytidine DeaminaseGerminal CenterSomatic Hypermutation, Immunoglobulin
- Access Rights
- Free to All
-
SETD2 Loss Creates A Permissive Epigenetic Landscape that Promotes Kidney Cancer Metastasis and Engenders Therapeutic Vulnerabilities
- Authors
- Xie, YuchenSahin, MerveCheng, Emily H.
- Description
Summary from GEO: "SETD2, a H3K36 trimethyltransferase, is frequently mutated in human cancers with the highest prevalence (13%) in clear cell renal cell carcinoma (ccRCC). Genomic profiling of primary ccRCC tumors reveals a positive correlation between SETD2 mutations and metastasis. However, whether and how SETD2-loss promotes metastasis remains unclear. Here, we detected SETD2 mutations in 24...
- Subject
-
Carcinoma, Renal CellEpigenesis, GeneticEpithelial CellsGenomicsHistone Chaperones
- Access Rights
- Free to All
-
Quiescent human glioblastoma cancer stem cells mediate tumor initiation, expansion, and recurrence following chemotherapy
- Authors
- Xie, Xuanhua P.Laks, Dan R.Ganbold, MungunsarnaiParada, Luis F.
- Description
Summary from GEO: "We performed single cell RNA sequencing with eight patient derived xenograft samples to identify quiescent cancer stem cells in glioblastoma. Additionally two samples treated with temozolomide was sequenced to examine the evolution of the cancer stem cells upon chemotherapeutics." Overall design from GEO: "Whole transcriptome single cell RNA sequencing with 10X method."
- Subject
-
GlioblastomaGlioblastoma/drug therapyHeterograftsNeoplastic Stem CellsSingle-Cell Gene Expression AnalysisTranscriptome
- Access Rights
- Free to All
-
Determinants of Response to Nivolumab plus Ipilimumab in a Phase II Trial of Advanced Salivary Gland Cancer Patients
- Description
Description from BioProject: "Salivary gland cancers (SGCs) are rare, aggressive cancers that lack effective treatments in the metastatic setting. We report the clinical results and immunogenomic correlates of response from a phase II trial evaluating nivolumab (anti-PD1) and ipilimumab (anti-CTLA4) in metastatic SGC patients."
- Subject
-
Clinical Trial, Phase IIExome SequencingIpilimumabNivolumabRNA-SeqSalivary Gland Neoplasms
- Access Rights
- Free to All